000			02893nam a2200169Ia 4500
008			140223b2010 xxu||||| |||| 00| 0 eng d
020			_a9788190343696 _c0.00
082			_a615.11 _bIND
100			_aMinistry of Health and Family Welfare, Government of India
245			_aIndian Pharmacopoeia 2010 Vol. III
260			_aGhaziabad _bIndian Pharmacopoeia Commission _c2010
300			_a1725 to 2829p
500			_a3 Volumes Set The 6th edition of the Indian Pharmacopoeia 2010 is published by the Indian Pharmacopoeia Commission (IPC) in accordance with a plan and completed through the untiring efforts of its members, Secretariat and Laboratory over a period of about two years. It supersedes the 2007 edition but any monograph of the earlier edition that does not figure in this edition continues to be official as stipulated in the Second Schedule of the Drugs and Cosmetics Act, 1940. This edition would be effective from 1st September, 2010.The Indian Pharmacopoeia 2010 is presented in three volumes. Volume I contains the Notices, Preface, the Structure of the IPC, Acknowledgements, Introduction, and the General Chapters. Volume II contains the General Notice, General Monographs on Dosage Forms, Monographs on drug substances, dosage forms and pharmaceutical aids (A to M). Volume III contains Monographs on drug substances, dosage forms and pharmaceutical aids (N to Z) followed by Monographs on Vaccines and Immunosera for Human use, Herbs and Herbal products, Blood and blood-related products, Biotechnology products and Veterinary products.The scope of the Pharmacopoeia has been extended to include products of biotechnology, indigenous herbs and herbal products, veterinary vaccines and additional antiretroviral drugs and formulations, inclusive of commonly used fixed-dose combinations. Standards for new drugs and drugs used under National Health Programmes are added and the drugs as well as their formulations not in use now a days are omitted from this edition. The number of monographs of Excipients, Anticancer drugs, Herbal products and Antiretroviral drugs have been increased in this edition. Monographs of Vaccines and Immunosera are also upgraded in view of development of latest technology in the field. A new chapter on Liposomal products and a monograph of Liposomal Amphotericin B injection is an added advantage in view of latest technology adopted for drug delivery. A chapter on NMR is incorporated in Appendices. The chapter on microbial contamination is also updated to a great extent to harmonise with prevailing international requirements.
600			_apharmacopoeia
890			_aIndia
995			_AIND _B009580 _CGEB-GEN _D5933.34 _E0 _F049 _H0 _I0.00 _J6666.67 11% (Set Price 20000.00) _L20100901 _M3 _UC _W20100924 _XHimanshu Book Co. _ZReference
999			_c15706 _d15706